Mixed Meal Tolerance Test (MMTT)

OTHER5 trials

Sponsors

University of Florida, University of Edinburgh, University of Exeter, Nanjing Medical University, Massachusetts General Hospital

Conditions

Genetic PredispositionHypoglycemiaMetabolic DiseasesMetabolism DisorderNutritionType 1 DiabetesType 2 Diabetes

Phase 1

Neulasta in Type 1 Diabetes

CompletedNCT00662519

University of FloridaType 1 Diabetes

Start: 2008-04-30End: 2014-03-31Updated: 2015-04-09

Phase 4

GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH

RecruitingNCT06003153

Massachusetts General HospitalGenetic Predisposition, Metabolic Diseases, Type 2 Diabetes

Start: 2024-03-12End: 2027-05-31Target: 125Updated: 2025-05-01

Unknown Phase

Energy Balance Following Islet Transplantation

TerminatedNCT03063229

University of EdinburghType 1 Diabetes

Start: 2016-06-30End: 2019-10-23Updated: 2019-10-25

Stimulated Glucagon as a Biomarker of Hypoglycemic Risk in Type 1 Diabetes

CompletedNCT05616273

University of ExeterHypoglycemia, Type 1 Diabetes

Start: 2023-05-03End: 2025-09-30Updated: 2025-12-19

Metabolites Profiling Reveals Nutrient Processing Patterns Upon Dietary Loading

CompletedNCT05784506

Nanjing Medical UniversityMetabolism Disorder, Nutrition

Start: 2023-09-01End: 2023-12-31Updated: 2025-09-18

Related Papers

253-OR: Circulating Neutrophil Numbers Increase with Age, but Are Not a Biomarker of T1D Risk

Diabetes2020-06-01